Search Results

There are 45587 results for: content related to: Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response

  1. Abstract of Papers Submitted to the American Association of the Study of Liver Disease

    Hepatology

    Volume 22, Issue S4, October 1995, Pages: S107–S514,

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840220703

  2. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22645

  3. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  4. You have free access to this content
    Poster Session 4: Acute Liver Failure and Artificial Liver Support; Diagnostics, Epidemiology, and Natural History

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1064A–1132A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28236

  5. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017

  6. Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study

    Journal of Viral Hepatitis

    Volume 22, Issue 9, September 2015, Pages: 708–717, B. Hajarizadeh, B. Grady, K. Page, A. Y. Kim, B. H. McGovern, A. L. Cox, T. M. Rice, R. Sacks-Davis, J. Bruneau, M. Morris, J. Amin, J. Schinkel, T. Applegate, L. Maher, M. Hellard, A. R. Lloyd, M. Prins, R. B. Geskus, G. J. Dore, J. Grebely and on behalf of the InC3 Study Group

    Version of Record online : 8 JAN 2015, DOI: 10.1111/jvh.12384

  7. You have free access to this content
    AASLD Abstracts (pp. 282A–382A)

    Hepatology

    Volume 38, Issue S4, October 2003, Pages: 282A–382A,

    Version of Record online : 10 FEB 2006, DOI: 10.1002/hep.1840380505

  8. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  9. You have free access to this content
    Aminoadamantanes for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Mieke H Lamers, Mark Broekman, Joost PH Drenth and Christian Gluud

    Published Online : 3 MAY 2014, DOI: 10.1002/14651858.CD010125.pub2

  10. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22759

  11. American association for the study of liver diseases

    Hepatology

    Volume 16, Issue S4, October 1992, Pages: 1A–292A,

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840160702

  12. Abstracts of papers submitted to the american association for the study of liver diseases

    Hepatology

    Volume 18, Issue S7, October 1993, Pages: 57A–346A,

    Version of Record online : 12 DEC 2005, DOI: 10.1002/hep.1840180703

  13. You have free access to this content
    Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children

    Hepatology

    Volume 53, Issue 6, June 2011, Pages: 1830–1838, Ángeles Ruiz-Extremera, José Antonio Muñoz-Gámez, María Angustias Salmerón-Ruiz, Paloma Muñoz de Rueda, Rosa Quiles-Pérez, Ana Gila-Medina, Jorge Casado, Ana Belén Martín, Laura Sanjuan-Nuñez, Ángel Carazo, Esther José Pavón, Esther Ocete-Hita, Josefa León and Javier Salmerón

    Version of Record online : 25 MAY 2011, DOI: 10.1002/hep.24298

  14. Clinical usefulness of total hepatitis C virus core antigen quantification to monitor the response to treatment with peginterferon alpha-2a plus ribavirin

    Journal of Viral Hepatitis

    Volume 12, Issue 5, September 2005, Pages: 481–487, V. González, E. Padilla, M. Diago, M. D. Giménez, R. Solà, L. Matas, S. Montoliu, R. M. Morillas, C. Pérez and R. Planas

    Version of Record online : 9 JUN 2005, DOI: 10.1111/j.1365-2893.2005.00628.x

  15. Abstracts of the international association for the study of the liver biennial Scientific meeting

    Hepatology

    Volume 19, Issue 4, April 1994, Pages: I1–I144,

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840190444

  16. You have free access to this content
    Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment

    Hepatology

    Volume 55, Issue 4, April 2012, Pages: 1048–1057, Patrick R. Harrington, Wen Zeng and Lisa K. Naeger

    Version of Record online : 1 MAR 2012, DOI: 10.1002/hep.24791

  17. You have free access to this content
    Abstracts 1 to 257

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 196A–298A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20923

  18. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  19. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  20. Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort

    Journal of Viral Hepatitis

    Volume 22, Issue 12, December 2015, Pages: 1020–1032, J. S. Doyle, K. Deterding, J. Grebely, H. Wedemeyer, R. Sacks-Davis, T. Spelman, G. Matthews, T. M. Rice, M. D. Morris, B. H. McGovern, A. Y. Kim, J. Bruneau, A. R. Lloyd, K. Page, M. P. Manns, M. E. Hellard, G. J. Dore and on behalf of the InC3 Study Group

    Version of Record online : 22 JUN 2015, DOI: 10.1111/jvh.12429